Gwan Hee Han
Overview
Explore the profile of Gwan Hee Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuk J, Kim M, Yoon S, Han G, Noh J
Obstet Gynecol
. 2025 Mar;
PMID: 40080821
Objective: To investigate the association between the duration of levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer risk in Korean women. Methods: A retrospective cohort study was conducted using the...
2.
Yuk J, Kim G, Kim D, Byun Y, Kim M, Yoon S, et al.
Eur J Endocrinol
. 2025 Mar;
PMID: 40073376
No abstract available.
3.
Shin H, Yang W, Kim J, Chang H, Yoo J, Choi W, et al.
Heliyon
. 2025 Mar;
11(4):e42539.
PMID: 40034272
The origins of epithelial ovarian cancer (EOC) have long been debated, with proposed sources including ovarian surface epithelial (OSE) cells, secondary Müllerian tract structures, or fallopian tube epithelium. Despite being...
4.
Yun H, Han G, Wee D, Chay D, Chung J, Kim J, et al.
Cancer Genomics Proteomics
. 2025 Feb;
22(2):271-284.
PMID: 39993806
Background/aim: This study investigated the relationship between E-cadherin down-regulation and enhanced pERK1/2 signaling in cervical cancer, evaluated their combined prognostic impact, and explored potential therapeutic targets. Materials And Methods: We...
5.
Han G, Kim Y, Park H, Yun H, Kim J, Kim M, et al.
Gynecol Oncol Rep
. 2025 Feb;
57:101670.
PMID: 39895896
Objectives: Ovarian mesonephric-like adenocarcinoma (MLA) is a rare malignancy with limited understanding of its molecular features and therapeutic vulnerabilities. Although similar to uterine MLA, its unique characteristics remain undefined. This...
6.
Yuk J, Kim G, Kim D, Byun Y, Kim M, Yoon S, et al.
Eur J Endocrinol
. 2025 Feb;
192(2):73-80.
PMID: 39895616
Objective: To evaluate the association between various regimens and combinations of menopausal hormone therapy (MHT) and the risk of cardiovascular disease (CVD) in clinical practice. Design: This was a population-based...
7.
Lee J, Seo J, Shin Y, Han G, Yoon S, Noh J, et al.
J Menopausal Med
. 2024 Sep;
30(2):78-87.
PMID: 39315500
Objectives: This study aimed to investigate the risk of osteoarthritis associated with menopausal hormone therapy (MHT). Methods: This population-based retrospective cohort study used a database of Korean health insurance claims...
8.
Han G, Kim H, Yun H, Chung J, Kim J, Cho H
Am J Cancer Res
. 2024 Jul;
14(6):3186-3197.
PMID: 39005664
This study developed a molecular classification model for cervical cancer using machine learning, integrating prognosis related biomarkers with clinical features. Analyzing 281 specimens, 27 biomarkers were identified, associated with recurrence...
9.
Yuk J, Noh J, Kim M, Han G, Kim J, Cho H, et al.
Menopause
. 2024 Jun;
31(8):686-692.
PMID: 38860931
Objective: Many studies have demonstrated that menopausal hormone therapy is associated with a reduced risk for colorectal cancer. This study investigated the relationship between specific hormone therapy regimens and colorectal...
10.
Han G, Kim H, Yun H, Kim J, Cho H
Target Oncol
. 2024 Feb;
19(2):251-262.
PMID: 38416378
Background: Despite improvement in progression-free survival (PFS) with poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) as maintenance treatment for patients with epithelial ovarian cancer (EOC), a comparative analysis of clinical events...